Meetings and Courses

Meetings and Courses

Announcements for this section should be submitted in the correct format at least 3 months before the required date of publication. This list is provided as a service to readers; inclusion does not imply endorsement by the Hepatobiliary & Pancreatic Diseases International.

Section editor

Shui-Ying Lei

Email: hbpdint@126.com

February, 2017

RNA therapeutics 2017

February 22-23, 2017; London, UK

SMi's 8th annual RNA therapeutics conference will feature a mix of case study-led presentations, panel debates, interactive workshops and keynote addresses tailored for an audience of professionals and research scientists looking to develop and commercialise novel RNA therapeutics and delivery systems. This exciting program for 2017 will showcase new developments through clinical and pre-clinical results in topics such as: messenger RNA-based therapeutics, anti-sense oligonucleotides and new sites for RNA silencing. Attendees are to: 1) Discover the exciting developments of mRNA and antisense oligonucleotide based therapeutics; 2) Find out how pharmaceutical and biotech companies are strategically improving drug delivery systems; 3) Discuss clinical developments and take away key lessons for future developments; 4) Understand the pharmacokinetic considerations of oligonucleotides and RNA therapies; and 5) Hear how the experts navigate the regulatory landscape. For further details and to register, please visit: http://www.therapeutics-rna.com/gelseiver.

3D cell culture

February 22-23, 2017; London, UK

3D cell culture 2017 will bring together leading professionals and researchers in the industry to discuss the latest developments and future potential of this technique. 3D cell culture 2017 will present success stories 3D culture applications, identifying the newest and brightest technologies, and the translation of 3D models into successful clinical and industrial applications. There will be emphasis on the success and future of 3D methods in organoid research, disease modeling and toxicology screening, stem cell research, and much more. Attendees include Directors, Supervisors, Specialists, Principal Scientists, Product Managers, Science Offcer, Chief Scientifc Offcer, CEO, COO, Project Manager, Lead Scientists, Senior Scientists, Project leaders, Labheads, Research Scientists, Engineers, Senior Pharmacologists, and Professors in the following areas: Cell culture; Stem cell and regenerative medicine; Process development -early and late stage; Large scale manufacturing; Cell therapy; Cell technology; High Throughput Screening; Assay development and screening; and Business development. For further information, please visit: http://www.smi-online.co.uk/pharmaceuticals/uk/3DCell-Culture?utm_medium=www.3d-cellculture. com&utm_source=P-220&utm_campaign=glob.

2nd exploring DNA repair pathways as targets for cancer therapy conference

February 27-March 2, 2017; Cancun, Mexico

The purpose of this conference is to bring together basic, translational and clinical investigators and discuss the current and future directions, opportunities and obstacles in the development of these anti-cancer modalities and how to best apply these concepts in clinical practice. Key sessions include: 1) Highlight recent advances in the feld of DNA damage repair; 2) Identify novel targets in DNA repair and checkpoint pathways; 3) Explore the concept of synthetic lethality for cancer treatment; 4) Assess the therapeutic potential of new anti-cancer modalities; and 5) Learn mechanisms of therapeutic resistance and ways to improve cancer therapy. For further information, please visit: https://www.fusion-conferences.com/conference46.php.

April

AACR annual meeting 2017

April 1-5, 2017; Walter E. Washington Convention Center, Washington, D.C., USA

The AACR annual meeting highlights the best cancer science and medicine from institutions all over the world. Program committee chair is Professor Kornelia Polyak from Dana-Farber Cancer Institute, Boston, Massachusetts. Attendees are invited to stretch their boundaries, form collaborations, attend sessions outside their own areas of expertise, and learn how to apply exciting new concepts, tools, and techniques to their own research. Continuing Medical Education Activity AMA PRA Category 1 Credits™ is available. For further information, please visit: http://www.aacr.org/Meetings/Pages/MeetingDetail.aspx?EventItemID=105&utm_source=aacrorg&utm_campaign=am17&utm_medium=mouseover.

The international liver congress™ 2017

April 19-23, 2017; Amsterdam, Netherlands

ILC 2017 provides a unique opportunity for clinicians and scientists from all over the world to meet not only to discuss clinical innovation and research challenges but also to interact socially, network and develop future collaborations. The 2017 ILC highlights comprise: 1) Post graduate course entitled “A multidisciplinary approach to patients with liver disease”; 2) State of the art lectures on liver transplantation for HCC and cell growth control in cancer therapy; 3) Basic science seminar on hepatic regenerative medicine; 4) Late breaker session; 5) Clinical Grand Rounds and symposia; 6) EASL Clinical Practice Guidelines sessions; 7) Fusion session; and 8) Young Investigators Forum and symposium. Selected sessions and posters will be webcasted and made available on the LiverTree™ for EASL members to view. For more information, please visit: website: https://ilc-congress.eu/.

European digestive surgery (EDS) 2017

April 27-29, 2017; Budapest, Hungary

The 11th European Digestive Surgery (EDS) postgraduate course will be held in Budapest, Hungary, on April 27-29, 2017. The EDS initial objective is to encourage the development and expansion of high quality surgical profession and to promote education in this feld. This two days postgraduate course can help attendees to learn more novelties from the surgery of the gastrointestinal tract. For more information, please contact: SCIENTIFIC COMMITTEE, European Digestive Surgery Department of General Surgery, Technical University of Munich, Ismaninger Strasse 22, 81675 Munich, Germany. Tel: +49-89-4140-2123; Fax: +49-89-4140-4870; Email:secretary@edsurgery.org. Website: http://www. eds2017.org/.

May

2017 joint international congress of ILTS, ELITA & LICAGE

May 24-27, 2017; Prague Congress Center, Czech Republic

The 2017 joint international congress of ILTS, ELITA & LICAGE will be held on May 24-27, 2017 at the Prague Congress Centre, Czech Republic. Over 1200 professionals from over 40 countries who are dedicated to promoting and learning about the scientifc advances in liver transplantation are brought together to discuss the latest advances in liver transplantation procedures and therapy. The goal of this congress is to broaden the education of scientists, surgeons, anesthesiologists, physicians, nurses, and organ procurement personnel in the care and treatment of liver transplant patients. For further information, please contact: ILTS 2017 Registration Department, Allison Jansen, Tel: +49-30-24603-410; Email: ilts2017registration@kit-group.org; website: http://2017. ilts.org/.

June

Cholangiocytes in health and disease: from basic science to novel treatments

June 9-11, 2017; Oslo, Norway

The conference will address major novel fndings on the pathophysiology of biliary diseases and bile acid metabolism; implications of the gains in knowledge on the current and future clinical practice will be discussed. It will be the perfect venue for young scientists and clinicians to present their work and listen to key opinion leaders about what will be important in science and in clinics in the coming years. Participants will learn about the development of the biliary tree, morphological features of cholangiocytes and their role in normal liver physiology and in the metabolism/homeostasis of bile acids. Moreover, the clinical features of cholangiopathies and the molecular mechanism triggering their development will be covered in detail, as well as new emerging diagnostic and therapeutic tools, biliary tree, anatomy and 3D structure, bioengineering, cholangiocyte pathophysiology, immunity, genetics, carcinogenesis, cholangiocarcinoma, clinical practice, biomarkers, diseases management. The deadline of abstract submission will be March 11, 2017. For more information, please visit: http://www.easl.eu/discover/events/detail/2017/cholangiocytes-in-health-and-disease-from-basic-science-tonovel-treatments.

10.1016/S1499-3872(16)60179-0)